Publications by authors named "Anna Maria Morelli"

Claim this Profile
C
Chemotherapy plus immunotherapy as first line combination in older patients with extensive stage small cell lung cancer: A systematic review and meta-analysis.
Valentina Bertaglia, Fausto Petrelli, Lorenzo Dottorini, Simona Carnio, Anna Maria Morelli

Semin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infections in lung cancer patients undergoing immunotherapy and targeted therapy: An overview on the current scenario.
Valentina Bertaglia, Anna Maria Morelli, Cinzia Solinas, Marco Maria Aiello, Silvia Manunta

Crit Rev Oncol Hematol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nutritional support in lung cancer: Time to combine immunonutrition with immunotherapy?
Sara Pilotto, Francesco Agustoni, Anna Maria Morelli, Federica Lobascio, Emanuele Cereda

Nutrition· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to and effectiveness of lenalidomide after 1 year of treatment in a real world setting.
Fiorenzo Santoleri, Ruggero Lasala, Elena Ranucci, Marco Rocchi, Stefano Pulini, Anna Maria Morelli

J Oncol Pharm Pract· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Infection with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.
Fausto Petrelli, Anna Maria Morelli, Andrea Luciani, Antonio Ghidini, Cinzia Solinas

Target Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
Michele Cavo, Francesca Gay, Meral Beksac, Lucia Pantani, Maria Teresa Petrucci, Anna Maria Morelli

Lancet Haematol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial.
Enrica Capelletto, Maria Rita Migliorino, Alessandro Morabito, Rita Chiari, Francesco Grossi, Anna Maria Morelli

Lung Cancer· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of glycemic parameters on venous thromboembolism risk prediction in gastrointestinal cancer.
Fiorella Guadagni, Silvia Riondino, Vincenzo Formica, Girolamo Del Monte, Anna Maria Morelli

World J Gastroenterol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visceral leishmaniasis in relapsed and overtreated multiple myeloma in the era of high dose and "novel agent" therapy.
Lorenza Torti, Stefano Pulini, Anna Maria Morelli, Francesco Bacci, Paolo Di Bartolomeo

Int J Hematol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in sex hormone levels after radical prostatectomy: Results of a longitudinal cohort study.
Mauro Gacci, Nicola Tosi, Gianni Vittori, Andrea Minervini, Giovanni Corona, Anna Maria Morelli

Oncol Lett· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis